Regenaplex Nr. 80a N
Regenaplex Nr. 80a N is a medicine authorised by Swissmedic under authorisation number 36509. The authorisation holder is Regena AG. The medicinal product code is Homeopathic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 July 1972 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 36509 |
|---|---|
| Name | Regenaplex Nr. 80a N |
| Full name | Regenaplex Nr. 80a N, Tropfen zum Einnehmen |
| Authorisation holder | Regena AG |
| Medicinal product code | Homeopathic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 14 July 1972 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Regenaplex Nr. 80a N, Tropfen zum Einnehmen | B | 15 July 2002 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 23 | 15 | ml | - | 20.01.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Regenaplex Nr. 80a N authorised in Switzerland?
Yes. Regenaplex Nr. 80a N is authorised by Swissmedic under authorisation number 36509, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Regenaplex Nr. 80a N have?
Regenaplex Nr. 80a N is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Regenaplex Nr. 80a N?
The authorisation holder is Regena AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.